Cibc Private Wealth Group, LLC Astrazeneca PLC Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 8,105,996 shares of AZN stock, worth $604 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
8,105,996
Previous 9,090,358
10.83%
Holding current value
$604 Million
Previous $708 Million
25.02%
% of portfolio
1.01%
Previous 1.32%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,355Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.5 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.06 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.8 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.79 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...